Insider Transactions in Q2 2021 at Vaccitech PLC (VACC)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 04
2021
|
Oxford Sciences Innovation PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
600,000
+6.38%
|
$10,200,000
$17.0 P/Share
|
|
May 04
2021
|
Oxford Sciences Innovation PLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
8,197,770
+29.18%
|
-
|
|
May 04
2021
|
Anne M. Phillips Director |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$51,000
$17.0 P/Share
|
|
May 04
2021
|
Joseph Scheeren Director |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$51,000
$17.0 P/Share
|
|
May 04
2021
|
Christopher Ellis Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
75
+50.0%
|
$1,275
$17.0 P/Share
|
|
May 04
2021
|
Robin Wright Director |
BUY
Open market or private purchase
|
Direct |
14,000
+36.36%
|
$238,000
$17.0 P/Share
|
|
May 04
2021
|
Graham Griffiths Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
100
+50.0%
|
$1,700
$17.0 P/Share
|
|
May 04
2021
|
Karen A Dawes Director |
BUY
Open market or private purchase
|
Direct |
1,700
+50.0%
|
$28,900
$17.0 P/Share
|
|
Apr 30
2021
|
M&G Investment Management LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
125,000
+10.3%
|
$1,750,000
$14.4 P/Share
|
|
Apr 29
2021
|
William Enright Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
455,775
+27.54%
|
-
|